Home » BARR OFFER FOR PLIVA D.D. APPROVED FOR PUBLICATION BY HANFA
BARR OFFER FOR PLIVA D.D. APPROVED FOR PUBLICATION BY HANFA
Barr Pharmaceuticals, Inc. announced that the Croatian Financial Services Supervisory Agency (HANFA) has approved for publication its tender offer for the purchase of 100% of the shares of PLIVA d.d., based in Zagreb, Croatia. Under the terms of the formal $2.3 billion cash tender offer, PLIVA shareholders who tender their shares will receive HRK 743 per share in cash.
Drug Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May